Rapid Micro Biosystems (RPID) Cash from Investing Activities (2020 - 2026)

Rapid Micro Biosystems' Cash from Investing Activities history runs 7 years deep, the most recent figure standing at $8.6 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 19.52% year-over-year to $8.6 million; the TTM figure through Mar 2026 stood at $12.2 million (down 63.8% YoY), while the FY2025 annual figure was $14.3 million, down 60.91% from the prior year.
• Cash from Investing Activities came in at $8.6 million for Q1 2026 at Rapid Micro Biosystems, up from $3.9 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $24.8 million in Q2 2024 to a low of -$99.5 million in Q1 2022.
• A 5-year average of $486235.3 and a median of $8.6 million in 2026 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities plunged 1846.41% in 2022 and surged 508.63% in 2023, its largest moves.
• Rapid Micro Biosystems' Cash from Investing Activities stood at $12.8 million in 2022, then dropped by 21.81% to $10.0 million in 2023, then tumbled by 51.41% to $4.9 million in 2024, then declined by 20.07% to $3.9 million in 2025, then surged by 121.15% to $8.6 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered $8.6 million, $3.9 million, and -$9.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison